In India Reversal, 44 Fixed-Dose Combination Drugs To Get June Approval
This article was originally published in PharmAsia News
Executive Summary
India's Drug Controller General of India has reversed itself and given approval to 44 of 294 combination drugs it originally rejected as irrational. The fixed-dose combinations include treatments for diarrhea, fever, hypertension and pain. The 44 cleared by the DGCI are expected to be approved in June, subject to the Drug Technical Advisory Board, which is expected to give its final approval soon. (Click here for more